The analyst firm also raised its EPS estimates for the health insurance company through 2015. Leerink analysts expect Cigna to report earnings of $7.37 a share for full year 2014, up from previous estimates of $7.30 a share. The firm raised its 2015 EPS estimates to $8.36 a share from $8.30 a share.
"After three quarters of spotty performance, CI has delivered a strong 3Q beating EPS by 13 c and raising estimates by 5 c, with solid core metrics," analyst Ana Gupta wrote. "This appears to be dispelling multiple bear thesis that have plagued the stock."
Must Read: Warren Buffett's 25 Favorite Stocks
Separately, TheStreet Ratings team rates CIGNA CORP as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate CIGNA CORP (CI) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, notable return on equity and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income."